{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:31Z","timestamp":1767134731036,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":28,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002204.pub3","type":"reference-entry","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T14:10:08Z","timestamp":1417183808000},"source":"Crossref","is-referenced-by-count":7,"title":["Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Heather E","family":"Elphick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W","family":"Southern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD002204.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"e36077","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron","year":"2012","journal-title":"PloS One"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD002204.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S1569-1993(08)60219-2","article-title":"Intravenous methylprednisolone pulse therapy vs. oral prednisone for allergic bronchopulmonary aspergillosis (ABPA) in CF [abstract]","volume":"7","author":"Cohen-Cymberknoh","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD002204.pub3-BIB3|cit3","unstructured":"Novartis An exploratory study to assess multiple doses of Omalizumab in patients with cystic fibrosis complicated by acute bronchopulmonary aspergillosis (ABPA) Clinicaltrials.gov (www.clinicaltrials.gov) (accessed 21\/01\/2013) 2008 ClinicalTrials.gov Identifier: NCT00787917"},{"issue":"Suppl 32","key":"10.1002\/14651858.CD002204.pub3-BIB4|cit4","first-page":"349, Abstract n","article-title":"Treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis: antifungal therapy with inhaled amphotericin B [abstract]","volume":"44","author":"Proesmans","year":"2009","journal-title":"Pediatric Pulmonology"},{"issue":"Article ID 3762","key":"10.1002\/14651858.CD002204.pub3-BIB5|cit5","first-page":"9 pages","article-title":"Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"2010","author":"Proesmans","year":"2010","journal-title":"International Journal of Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD002204.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.44.11.925","article-title":"Corticosteroid treatment and prognosis in pulmonary eosinophilia","volume":"44","author":"Capewell","year":"1989","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD002204.pub3-BIB7|cit7","unstructured":"Cystic Fibrosis Foundation National Patient Registry Annual Data Report [Bethesda, Maryland] 2000"},{"issue":"3","key":"10.1002\/14651858.CD002204.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1378\/chest.100.3.813","article-title":"Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole","volume":"100","author":"Denning","year":"1991","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD002204.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0732-8893(92)90053-V","article-title":"In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents","volume":"15","author":"Denning","year":"1992","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD002204.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.116.3.639","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics","volume":"116","author":"Geller","year":"1999","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002204.pub3-BIB11|cit11","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD002204.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1286-4579(99)80518-8","article-title":"Pathogenicity of microbes associated with cystic fibrosis","volume":"1","author":"Hutchison","year":"1999","journal-title":"Microbes and Infection"},{"issue":"12","key":"10.1002\/14651858.CD002204.pub3-BIB13|cit13","first-page":"851","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"The Lancet"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD002204.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0091-6749(84)90482-2","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"73","author":"Laufer","year":"1984","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"Suppl B","key":"10.1002\/14651858.CD002204.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/28.suppl_B.83","article-title":"Liposomal amphotericin B: safety data from a phase 2\/3 clinical trial","volume":"28","author":"Meunier","year":"1991","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD002204.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.105.1.32","article-title":"Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"105","author":"Mroueh","year":"1994","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD002204.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1378\/chest.115.2.364","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole","volume":"115","author":"Nepomuceno","year":"1999","journal-title":"Chest"},{"issue":"12","key":"10.1002\/14651858.CD002204.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/thx.50.12.1321","article-title":"Use of nebulised liposomal amphotericin B in the treatmenof Aspergillus fumigatus empyema","volume":"50","author":"Purcell","year":"1995","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD002204.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9343(78)90579-X","article-title":"The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis","volume":"64","author":"Rosenberg","year":"1978","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002204.pub3-BIB20|cit20","first-page":"450","article-title":"Five year follow-up of allergic bronchopulmonary aspergillosis","volume":"108","author":"Safirstein","year":"1973","journal-title":"American Review of Respiratory Disease"},{"issue":"5","key":"10.1002\/14651858.CD002204.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/adc.65.5.507","article-title":"Cystic fibrosis and allergic bronchopulmonary aspergillosis","volume":"65","author":"Simmonds","year":"1990","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD002204.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09031936.02.00248002","article-title":"Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide","volume":"20","author":"Skov","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"11","key":"10.1002\/14651858.CD002204.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomised trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002204.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0889-8561(05)70018-7","article-title":"Allergic bronchopulmonary aspergillosis: clinical perspectives","volume":"18","author":"Varkey","year":"1998","journal-title":"Immunology and allergy clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD002204.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mai.2003.1388","article-title":"Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomised controlled trial","volume":"111","author":"Wark","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD002204.pub3-BIB26|cit26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001108.pub2","article-title":"Azoles for allergic bronchopulmonary aspergillosis","author":"Wark","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002204.pub3-BIB27|cit27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Elphick","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD002204.pub3-BIB28|cit28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002204.pub2","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Elphick","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002204.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002204.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:10:22Z","timestamp":1628529022000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002204.pub3"}},"subtitle":[],"editor":[{"given":"Heather E","family":"Elphick","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002204.pub3","relation":{},"subject":[],"published":{"date-parts":[[2014,11,28]]}}}